Entrada Therapeutics Inc (TRDA)
19.21
-0.02
(-0.10%)
USD |
NASDAQ |
Nov 08, 11:34
Entrada Therapeutics Revenue (TTM): 215.23M for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
September 30, 2024 | 215.23M |
June 30, 2024 | 239.40M |
Date | Value |
---|---|
March 31, 2024 | 162.87M |
December 31, 2023 | 129.01M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
129.01M
Minimum
Dec 2023
239.40M
Maximum
Jun 2024
186.63M
Average
189.05M
Median
Revenue (TTM) Benchmarks
Fulcrum Therapeutics Inc | -- |
Sarepta Therapeutics Inc | 1.640B |
Catalyst Pharmaceuticals Inc | 460.48M |
Vertex Pharmaceuticals Inc | 10.63B |
Regenxbio Inc | 84.33M |